Comparison of Intraperitoneal Bupivacaine and Saline Irrigation for Pain Relief After Laparoscopic Cholecystectomy
1 other identifier
interventional
106
1 country
1
Brief Summary
This randomized clinical trial compared intraperitoneal irrigation of bupivacaine(a local anesthetic) vs a control group receiving normal saline for relief of post operative pain following laparoscopic gallbladder surgery. A total of 106 patients divided into two equal groups, with one group receiving bupivacaine and the other treated using normal saline(control).Previous studies on the subject found that bupivacaine significantly reduced postoperative pain. Although conventional intravenous analgesics remain widely used, bupivacaine may be a better option, especially in difficult surgical cases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4 postoperative-pain
Started Jul 2026
Shorter than P25 for phase_4 postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 6, 2026
CompletedFirst Posted
Study publicly available on registry
June 16, 2026
CompletedStudy Start
First participant enrolled
July 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
June 16, 2026
June 1, 2026
5 months
June 6, 2026
June 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Post operative pain relief
The study primarily aimed to compare post operative pain relief following intraperitoneal irrigation of bupivacaine vs normal saline.
From the completion of the procedure til one hour after surgery
Study Arms (2)
Experimental : group A: bupivacaine
EXPERIMENTALGroup A is the arm where patients have received intraperitoneal bupivacaine during laparoscopic gallbladder surgery, and their post operative pain is compared .
Placebo : group B: saline
PLACEBO COMPARATORPlacebo : group B: saline Group B is the arm where patients have received only intraperitoneal normal saline .
Interventions
In group A intraperitoneal bupivacaine is used for pain relief
In group B intraperitoneal saline is used for pain relief as placebo.
Eligibility Criteria
You may qualify if:
- Adult consented patients of any gender aged 18 to 60 years Fit to undergo elective laparoscopic cholecystectomy
You may not qualify if:
- Patients who had developed choledocholithiasis or pancreatitis pre-operatively
- Where conversion to open cholecystectomy is needed intraoperatively
- Pregnant or lactating
- Inability to express pain appropriately, like in psychiatric disorders
- With any contraindication to the use of bupivacaine or normal saline, e.g., hypersensitivity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wah Medical College, POF Hospital Wah cantt Wāh
Wāh, Punjab Province, 47040, Pakistan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- This study was conducted as a double-blinded randomized controlled trial. In this design, the outcome assessor (observer) was blinded to the group allocation, while the operating surgeon was also not aware of the intervention being performed.Blinding was achieved by ensuring that the trained observer responsible for recording postoperative outcomes, including post operative pain, did not know whether bupivacaine or normal saline was used during the procedure. This helped to minimize observer bias in outcome measurement
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 6, 2026
First Posted
June 16, 2026
Study Start
July 1, 2026
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
June 16, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, CSR
- Time Frame
- 1 year after publication of article in journal